Open AccessNetwork Meta‐Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid‐Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low‐Density Lipoprotein Cholesterol
Author(s) -
Peter P. Tóth,
Sarah Bray,
Guillermo Villa,
Tamara Palagashvili,
Naveed Sattar,
Erik S.G. Stroes,
Gavin Worth
Publication year - 2022
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.122.025551
Subject(s) - alirocumab , ezetimibe , evolocumab , medicine , statin , placebo , randomized controlled trial , pcsk9 , apolipoprotein b , lipoprotein , cholesterol , pharmacology , endocrinology , apolipoprotein a1 , ldl receptor , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom